InsiderPulse
← 10-K / 10-Q
10-QSONM

DNA X, Inc.

Filed 2026-05-20Period ending 2026-03-31
EDGAR ↗All periods →

Income Statement

Line Item2026-03-31Q/QY/Y
SG&A Expense$3.6M+27.4%
Operating Income-$3.6M-660.9%
Interest Expense$131K+84.5%
Pre-tax Income-$3.9M-765.8%
Income Tax$2.5M+1822.7%
Net Income$6.3M+1284.3%
EPS (Basic)$5.01+6162.5%
EPS (Diluted)$5.01+6162.5%

Balance Sheet

Line Item2026-03-31Q/QY/Y
Cash & Equivalents$1.2M-8.3%-43.5%
Accounts Receivable$1.5M-69.1%
Current Assets$3.3M-88.6%-87.7%
Total Assets$4.8M-89.0%-86.5%
Current Liabilities$4.3M-91.0%-87.5%
Long-term Debt$1.1M-78.8%-62.1%
Total Liabilities$4.9M-90.3%-86.7%
Stockholders' Equity-$983K+87.6%+8.9%

Cash Flow

Line Item2026-03-31Q/QY/Y
Operating Cash Flow-$3.5M+63.9%
Investing Cash Flow$3.4M
Financing Cash Flow$6.4M+0.0%